Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 3/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2900135 | 1.00 | MEN1 (0.43) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL21647611 | 1.00 | MEN1 (0.43) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL28054343 | 1.00 | MEN1 (0.43) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL28826404 | 1.00 | MEN1 (0.43) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL28457008 | 1.00 | MEN1 (0.43) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL28457026 | 1.00 | MEN1 (0.43) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL287739 | 1.00 | MEN1 (0.43) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL28462442 | 1.00 | MEN1 (0.43) | MEN1KMT2AALDH1A1LMNATSHR | |
| Hydrochloric Acid SCHEMBL28261063 | 0.98 | MEN1 (0.41) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL872485 | 0.98 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116370648-A | Chemotherapeutic drug-polymer conjugate capable of triggering active transcellular transport and preparation method and application thereof | 复旦大学 | 2023-07-04 | — | — | CN | claimed |
| JP-61134381-A | — | — | None | — | — | JP | disclosed |
| US-20260146064-A1 | PH-SENSITIVE MEMBRANE DISRUPTIVE PEPTIDES AND USE THEREOF | SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) | 2026-05-28 | — | — | US | disclosed |
| US-12528903-B2 | Block copolymer and micelle compositions and methods of use thereof | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-01-20 | — | — | US | disclosed |
| US-12091486-B2 | Block copolymer and micelle compositions and methods of use thereof | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-09-17 | — | — | US | disclosed |
| EP-4313937-A1 | IONIZABLE LIPIDS AND LIPID NANOPARTICLES COMPRISING SAID IONIZABLE LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS | Universiteit Gent (BE) | 2024-02-07 | — | — | EP | disclosed |
| CN-116370648-A | Chemotherapeutic drug-polymer conjugate capable of triggering active transcellular transport and preparation method and application thereof | 复旦大学 | 2023-07-04 | — | — | CN | disclosed |
| US-20230085899-A1 | NOVEL BLOCK COPOLYMER AND MICELLE COMPOSITIONS AND METHODS OF USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-03-23 | — | — | US | disclosed |
| WO-2022207938-A1 | IONIZABLE LIPIDS AND LIPID NANOPARTICLES COMPRISING SAID IONIZABLE LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS | UNIVERSITEIT GENT (BE) | 2022-10-06 | — | — | WO | disclosed |
| US-20220226510-A1 | STIMULI-RESPONSIVE NANOPARTICLES FOR BIOMEDICAL APPLICATIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-07-21 | — | — | US | disclosed |
| US-5457205-A | Substituted thiazoles useful for treatment of diabetes | DR. KARL THOMAE GMBH (DE) | 1995-10-10 | — | — | US | disclosed |
| US-5232946-A | Promoting weight gain and reduction of blood sugar and fat deposits in animals, feed efficiency | DR. KARL THOMAE GMBH (DE) | 1993-08-03 | — | — | US | disclosed |
| US-5219852-A | Hypoglycemic agents, treatment of diabetes and obesity | DR. KARL THOMAE GMBH (DE) | 1993-06-15 | — | — | US | disclosed |
| US-5026702-A | Enhances physical performance in animals, effective in lowering blood sugar, reducing body fat and lowering atherogenic lipoproteins | DR. KARL THOMAE, GMBH (DE) | 1991-06-25 | — | — | US | disclosed |
| US-4886814-A | LOWER BLOOD SUGAR | DR. KARL THOMAS GMBH (DE) | 1989-12-12 | — | — | US | disclosed |
| JP-S61134381-A | PRODUCTION OF 2-HEXAMETHYLENEIMINOETHYL ACRYLATE | MITSUBISHI PETROCHEM CO LTD | 1986-06-21 | — | — | JP | disclosed |
| US-4287209-A | USEFUL AS METABOLIC REGULATORS, AND HERBICIDES | SOCIETE DE RECHERCHES INDUSTRIELLES (S.O.R.I.) (FR) | 1981-09-01 | — | — | US | disclosed |
| US-4235896-A | Benzyl-phenoxy acid esters and hyperlipaemia compositions containing the same | ORCHIMED S.A. (CH) | 1980-11-25 | — | — | US | disclosed |
| US-4179515-A | HYPOLIPEMIC, HYPOCHOLESTEROLEMIC, CHOLAGOGIC | ORCHIMED S. A. (CH) | 1979-12-18 | — | — | US | disclosed |
| US-4146385-A | METABOLIC REGULATORS, CARDIOVASCULAR AGENTS, HERBICIDES | SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I. (FR) | 1979-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230085899-A1 | NOVEL BLOCK COPOLYMER AND MICELLE COMPOSITIONS AND METHODS OF USE THEREOF | FOLR2, FOLR1, MPC2 | MEN1 1278/4885KMT2A 1079/4885ALDH1A1 3441/4885 |
| US-20260146064-A1 | PH-SENSITIVE MEMBRANE DISRUPTIVE PEPTIDES AND USE THEREOF | LNPK, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, YWHAZ | MEN1 592/4885KMT2A 4382/4885ALDH1A1 4676/4885 |
| US-12528903-B2 | Block copolymer and micelle compositions and methods of use thereof | PHOSPHO1, SGMS1, PCTP | MEN1 279/4885KMT2A 1592/4885ALDH1A1 2708/4885 |
| US-12091486-B2 | Block copolymer and micelle compositions and methods of use thereof | FOLR2, FOLR1, MPC2 | MEN1 1114/4885KMT2A 930/4885ALDH1A1 3141/4885 |
| US-20220226510-A1 | STIMULI-RESPONSIVE NANOPARTICLES FOR BIOMEDICAL APPLICATIONS | HSPA9, LRBA, AHSA1 | MEN1 1698/4885KMT2A 4687/4885ALDH1A1 4542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.